Atomwise

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

Komodo Health is a healthcare technology company that provides software applications to enable users to deliver exceptional value to their customers, colleagues, and patients. The company's Healthcare Map is the industry's most precise view of the U.S. healthcare system, and it combines the world's most comprehensive view of patient-encounters with innovative algorithms and decades of clinical expertise. Komodo Health's software applications are used by life sciences companies, payers, providers, and consultancies to improve the certainty of pre-launch plans, calculate Rx-based ROI for digital marketing, find patients with complicated or rare conditions, and more.

SOMA is a Research Automation Platform that accelerates medical innovation by providing up to 100x speedup through process automation. The platform collates and analyzes medical research articles, extracting important concepts and identifying causal and associative relationships between them. It organizes this information into a specialized database forming a knowledge graph. Researchers can retrieve causal chains, access specific research articles, and perform tasks like concept analysis, drug repurposing, and target discovery. SOMA enhances literature review by finding relevant articles based on the mechanism of action, saving time on organizing reviews and allowing researchers to focus on their own research. The platform offers freemium access with basic functionality for free indefinitely, with the option to subscribe to advanced features after a 14-day trial period.

Fathom5 is a company that specializes in the intersection of AI and industrial systems. They offer a range of products and services to help customers build more resilient, flexible, and efficient industrial systems. Fathom5's approach is unique in that they take a security-first approach to cyber-physical system design. This means that security is built into every stage of the development process, from ideation to engineering to testing to deployment. This approach has been proven to achieve higher system resiliency and faster regulatory compliance at a reduced cost.

Bloomberg is a leading global provider of financial data, news, and analytics. The company is known for its innovative technology solutions, including the Bloomberg Terminal, which revolutionized the industry by delivering critical insights and actionable information to financial decision-makers. Bloomberg is at the forefront of artificial intelligence, machine learning, and natural language processing, offering tools and automated workflows to help clients navigate the vast amount of data available in the financial markets. With a focus on engineering value for customers and keeping humans in the loop, Bloomberg continues to drive innovation and provide cutting-edge technology solutions for over 325,000 financial professionals worldwide.

Tremello is a market research platform that uses AI to deliver off-market data. It combines a leading AI engine with human experts to provide bespoke intelligence delivered directly to the user's inbox. Tremello's AI analyzes relationships, identifies patterns, and considers the broader context, delivering meaningful and actionable insights on top of a base human layer. It leverages a diverse range of data sources, including public and private databases, industry reports, social media archives, company websites, and government filings, ensuring a complete and comprehensive picture of the research subject.

The AI in Finance Summit is a leading conference that brings together experts in artificial intelligence and finance to discuss the latest trends and developments in the field. The summit features a variety of speakers, including researchers, practitioners, and investors, who share their insights on how AI is being used to transform the financial industry. The summit also provides a platform for attendees to network and learn from each other.

Kavout is an AI-powered financial research assistant that provides investors with data-driven insights and cutting-edge technology to help them make informed investment decisions. The platform offers a range of features, including natural language search, stock screening, portfolio analysis, and personalized recommendations. Kavout's AI algorithms adapt to each user's unique investment style, providing tailored insights and guidance.

AnswerTime is an AI-led research tool that leverages artificial intelligence to provide quick and accurate answers to a wide range of research questions. The platform is designed to assist users in finding relevant information efficiently, saving time and effort in the research process. AnswerTime utilizes advanced algorithms to analyze and process data from various sources, delivering reliable results in a matter of seconds. With its user-friendly interface and powerful AI capabilities, AnswerTime is a valuable tool for students, professionals, and researchers seeking to enhance their research productivity.

Biyond is a comprehensive platform that provides insightful crypto investment guidance through a combination of expert analysis, advanced trading indicators, and AI-powered tools. It empowers users with actionable market intelligence, enabling them to make informed investment decisions and navigate the complexities of the cryptocurrency market. Biyond's unique trading indicators, driven by machine learning models, offer a competitive edge, while its investable portfolios cater to diverse investment objectives. The platform's team of professional traders, data scientists, and AI experts provides valuable insights and support, making Biyond a trusted source for crypto investors of all experience levels.

PumasAI is an AI tool designed to accelerate access to life-saving treatments for patients by providing data analytics tools and personalized treatments for drug development and healthcare delivery needs. The company has been recognized for its innovative contributions to the pharmaceutical industry, helping in making data-driven decisions more efficiently. PumasAI aims to save time and money for its clients through its fine-tuned offerings and successful regulatory submissions.

DealGraph is an AI-powered platform that helps users explore business networks by leveraging hidden relationships among organizations. By analyzing unstructured texts and images, DealGraph provides Relationship Intelligence, allowing users to gain instant knowledge of connections their prospects, customers, or competitors have with other organizations. The platform offers Relationship Alerts to notify users of new relationships, enabling them to uncover crucial insights and opportunities without the need for extensive research. DealGraph also features a Relationship Graph that visualizes organization networks through interactive graphs, answering key questions about market dynamics, customer relationships, industry trends, and supply chain structures. It caters to various users, including sales teams for prospecting, investors for company research, and corporate development teams for market overviews.

InsightQ.ai is a pioneering force in the world of Artificial Intelligence for Product Management. Its groundbreaking AI product manager, CoPilot, is an indispensable companion on the path to product success, offering a seamless and transformative experience for product managers. InsightQ.ai CoPilot can effortlessly create a variety of essential documents that are invaluable to product managers, including product roadmaps, user personas, competitive analysis, and go-to-market strategies. It seamlessly integrates with key platforms like Atlassian and Slack, and connects with over 5,000 other services through Zapier, ensuring a cohesive and efficient workflow across all project management tools.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Kuano is an AI tool that focuses on redefining drug discovery using Quantum and AI technologies. The platform offers world-class scientific expertise in quantum physics, AI, and medicinal chemistry to revolutionize the drug design process. Kuano aims to leverage cutting-edge technologies to accelerate the discovery of new drugs and improve healthcare outcomes.

System Pro is a cutting-edge platform that revolutionizes the way users search, synthesize, and contextualize scientific research, with a primary focus on health and life sciences. It offers a fast and reliable solution for accessing valuable information in the field of research, empowering users to stay informed and make informed decisions. By leveraging advanced technology, System Pro enhances the research experience by providing a seamless and efficient search process, enabling users to discover relevant content effortlessly.

Synthace is a software and expertise platform designed for Discovery Biology Teams to streamline and optimize their experiments in assay development, media optimization, and purification process development. The platform offers software solutions, training, and on-site support from specialists to help scientists conduct experiments more efficiently and effectively. By leveraging multifactorial methods and automation, Synthace aims to accelerate drug discovery processes and deliver faster, definitive results.

Valo is a company that uses AI-driven technology to transform the discovery and development of life-changing medicines. They combine machine learning, tissue biology, and patient data to create a suite of powerful capabilities that bring the future of drug discovery and development to bear. Valo's team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers are dedicated to advancing the combined power of technology and patient data.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Deepcell is a company that develops technology for single-cell analysis. Their REM-I platform combines label-free imaging, deep learning, and gentle sorting to leverage single cell morphology as a high-dimensional quantitative readout. This allows researchers to gain insights into cells' phenotype and function to address important research questions across biology.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Allchemy is a resource-aware AI platform for drug discovery. It combines state-of-the-art computational synthesis with AI algorithms to predict molecular properties. Within minutes, Allchemy creates thousands of synthesizable lead candidates meeting user-defined profiles of drug-likeness, affinity towards specific proteins, toxicity, and a range of other physical-chemical measures. Allchemy encompasses the entire resource-to-drug design process and has been used in academic, corporate and classified environments worldwide to: Design synthesizable leads targeting specific proteins Evolve scaffolds similar to desired drugs Design “circular” drug syntheses from renewable materials Interface with and instruct automated synthesis platforms and optimize pilot-scale processes Operate “iterative synthesis” schemes Predict side reactions and create forensic “synthetic signatures” of hazardous/toxic molecules Design synthetic degradation and recovery cycles for various types of feedstocks and functional target molecules

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Wildlife Insights is an AI application that brings cutting-edge technology to wildlife conservation. It streamlines decision-making by providing machine learning models and tools to manage, analyze, and share camera trap data. Users can easily upload, identify, analyze, and discover wildlife through the platform, enabling better decisions to help wildlife thrive globally.

BioloGPT is an AI tool designed to answer biology-related questions with insights and graphs. It provides information on various topics such as maintaining a healthy gut microbiome, foods for a healthy immune system, effects of cannabis on the brain, risks of Covid-19 vaccines, and advancements in psoriasis treatment. The tool is updated daily and cites full papers to support its answers.

Bichos ID de Fucesa is an AI tool that allows users to explore and identify insects, arachnids, and other arthropods using artificial intelligence. Users can discover the most searched bugs, explore new discoveries made by the community, and view curated organisms. The platform aims to expand knowledge about the fascinating world of arthropods through AI-powered identification.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

CellProfiler is an AI tool designed for biologists to analyze and process images automatically. It allows users to load image-processing modules, adjust settings, measure phenotypes, export data, and classify phenotypes using machine learning. The application is user-friendly and provides a seamless experience for biologists to analyze complex or subtle phenotypes in their images.

Salt AI is a development engine tailored for life sciences organizations, aiming to accelerate advancements in the field by enabling faster adoption and utilization of AI technologies. The platform offers reliable and reproducible AI processes, optimized for speed and efficiency, and promotes transparency and collaboration within workflows. With a focus on supporting best-in-class life sciences research models, Salt AI empowers users to enhance their understanding of biological processes through flexible and performant AI solutions.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that helps in drug development by providing accurate predictions for small molecule drugs. The application utilizes AI technology to optimize solid-state formulations, reduce turnaround time, mitigate risks, and discover novel polymorphs, ultimately streamlining the pharmaceutical research and development process.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

C&EN, a publication of the American Chemical Society, provides the latest news and insights on the chemical industry, including research, technology, business, and policy. It covers a wide range of topics, including analytical chemistry, biological chemistry, business, careers, education, energy, environment, food, materials, people, pharmaceuticals, physical chemistry, policy, research integrity, safety, and synthesis.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Cambrian Copilot is an AI tool designed for researchers and engineers to stay up-to-date with the latest machine learning research. It provides a platform to search over 240,000 ML papers, understand complex details, and automate literature reviews, making the process more efficient and accessible.

Mnemonic AI is an advanced Customer Intelligence AI tool that specializes in creating AI Personas and Digital Twin of the Customer. It helps organizations of all sizes better understand individuals by developing artificial intelligence solutions to tailor messages to their state of mind. The tool offers features such as Buyer Persona Creation, Digital Twin of the Customer, Case Studies, Whitepaper, OCEAN Personality Analysis, Schwartz Universal Values, and easy data source integrations.

functime is a time-series machine learning tool designed for scalable analysis. It offers a comprehensive set of functions for forecasting, evaluation, and analysis of time-series data. With features like scoring, ranking, and plotting functions, functime simplifies the process of evaluating thousands of forecasts simultaneously. It serves as an AI copilot to help analysts analyze and compare trends, seasonality, and causal factors in forecasts. The tool also provides detailed API reference for seamless integration into existing workflows.

Kolank is an AI tool that offers a unified API for various AI models, including Generative AI. It provides features such as load balancing, fallbacks, cost and performance metrics. Users can easily access and utilize AI models for tasks like text generation, image analysis, and video processing. Kolank simplifies the integration of AI capabilities into applications, making it a valuable resource for developers and businesses seeking to leverage AI technology.

Promptmakr is an AI-powered platform that serves as a marketplace for buying and selling AI prompts. It provides a convenient space for users to access a variety of prompts for their AI projects. With a user-friendly interface, Promptmakr aims to streamline the process of acquiring prompts and enhancing the efficiency of AI development. Whether you are a developer looking for inspiration or a business seeking tailored prompts, Promptmakr offers a diverse range of options to meet your needs.